Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)
Encontrada(s) 1 página(s)
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/345726
. 2011
SAFETY AND IMMUNOGENICITY OF A MODIFIED POX VECTOR-BASED HIV/AIDS VACCINE CANDIDATE EXPRESSING ENV, GAG, POL AND NEF PROTEINS OF HIV-1 SUBTYPE B (MVA-B) IN HEALTHY HIV-1-UNINFECTED VOLUNTEERS: A PHASE I CLINICAL TRIAL (RISVAC02)
- García, Felipe
- Bernaldo de Quirós, Juan Carlos López
- Gómez, Carmen E
- Perdiguero, Beatriz
- Nájera, Jose L
- Jiménez, Victoria
- GARCIA ARRIAZA, JUAN FRANCISCO
- Guardo, Alberto C
- Pérez, Iñaki
- Díaz-Brito, Vicens
- Conde, Matilde Sánchez
- González, Nuria
- Alvarez, Amparo
- Alcamí, José
- Jiménez, José Luis
- Pich, Judit
- Arnaiz, Joan Albert
- Maleno, María J
- León, Agathe
- Muñoz-Fernández, María Angeles
- Liljeström, Peter
- Weber, Jonathan
- Pantaleo, Giuseppe
- Gatell, José M
- Plana, Montserrat
- Esteban, Mariano
To investigate the safety and immunogenicity of a modified vaccinia virus Ankara vector expressing HIV-1 antigens from clade B (MVA-B), a phase-I, doubled-blind placebo-controlled trial was performed., Peer reviewed
Proyecto: //
DOI: http://hdl.handle.net/10261/345726, https://api.elsevier.com/content/abstract/scopus_id/80054003999
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/345726
HANDLE: http://hdl.handle.net/10261/345726, https://api.elsevier.com/content/abstract/scopus_id/80054003999
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/345726
PMID: http://hdl.handle.net/10261/345726, https://api.elsevier.com/content/abstract/scopus_id/80054003999
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/345726
Ver en: http://hdl.handle.net/10261/345726, https://api.elsevier.com/content/abstract/scopus_id/80054003999
Digital.CSIC. Repositorio Institucional del CSIC
oai:digital.csic.es:10261/345726
Advanced search